<DOC>
	<DOC>NCT01620255</DOC>
	<brief_summary>To determine the dose or doses of PF-00547659 that will be the most effective to improve or halt the disease symptoms in patients with moderate to severe ulcerative colitis.</brief_summary>
	<brief_title>A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis, Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>Subjects with diagnosis of Ulcerative Colitis for 3 or more months. Ulcerative colitis must be active beyond the rectum. Must active Ulcerative Colitis with a Total Mayo Score of 6 to 12 points Pregnant or breast feeding. Diagnosis of indeterminate colitis or Crohn's Disease Subjects with history of colonic or small bowel obstruction or resection.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>